• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

10

CATEGORIES

  • 62
  • 23
  • 17
  • 6
  • 6
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1

PRICE

55
57
105
126

PUBLISHED

0
7
23
126

PRODUCT TYPE

115
11

Search "Innate Pharma S.A." returned 126 results.

PRODUCT TITLE
Innate Pharma SA - Product Pipeline Review - 2012 Innate Pharma SA - Product Pipeline Review - 2012 - Product Thumbnail Image

Innate Pharma SA - Product Pipeline Review - 2012

Innate Pharma SA – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Innate Pharma SA - Product Pipeline Review - 2012” provides data on the Innate Pharma SA’s...

December 2012
FROM

Innate Pharma SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM

Innate Pharma SA - Product Pipeline Review - 2013

Innate Pharma SA - Product Pipeline Review - 2013 Summary “Innate Pharma SA - Product Pipeline Review - 2013” provides data on the Innate Pharma SA’s research and development focus. The report includes...

October 2013
FROM
Innate Pharma SA - Product Pipeline Review - Q4 2010 Innate Pharma SA - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

Innate Pharma SA - Product Pipeline Review - Q4 2010

Innate Pharma SA – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Innate Pharma SA - Product Pipeline Review - Q4 2010” provides data on the company’s research...

December 2010
FROM

Innate Pharma SA - Product Pipeline Review - 2014

Innate Pharma SA - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Innate Pharma SA - Product Pipeline Review - 2014’, provides an overview of the Innate Pharma SA’s pharmaceutical...

June 2014
FROM

Colitis - Pipeline Review, H2 2013

Colitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Colitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Influenza A Infections - Pipeline Review, H2 2013

Influenza A Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Influenza A Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

August 2013
FROM
The Future of the Biologicals Market: Market overview, innovations and company profiles The Future of the Biologicals Market: Market overview, innovations and company profiles - Product Thumbnail Image

The Future of the Biologicals Market: Market overview, innovations and company profiles

Biopharmaceutical products are the key to the future of the pharmaceutical market Even before the market stagnation seen in 2009 due to the recession, conventional pharmaceuticals were facing drastic...

March 2010
FROM

Bladder Cancer - Pipeline Review, H2 2013

Bladder Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bladder Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Gynecological Cancer - Pipeline Review, H1 2013

Gynecological Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gynecological Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

May 2013
FROM
Transgene SA - Product Pipeline Review - 2012 Transgene SA - Product Pipeline Review - 2012 - Product Thumbnail Image

Transgene SA - Product Pipeline Review - 2012

Transgene SA – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Transgene SA - Product Pipeline Review - 2012” provides data on the Transgene SA’s research and...

June 2012
FROM
Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Acute Myeloid Leukemia (AML) Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World...

July 2012
FROM

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2013

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Multiple Myeloma (Kahler's Disease) - Pipeline Review, H2 2013', provides an overview of the indication’s...

September 2013
FROM

Post-Operative Pain - Pipeline Review, H1 2013

Post-Operative Pain – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Post-Operative Pain - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

June 2013
FROM

The Neurotechnology Industry 2013 Report

Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets...

August 2013
FROM

Influenza - Pipeline Review, H2 2013

Influenza - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Influenza - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM
Transgene SA - Product Pipeline Review - H2 2011 Transgene SA - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Transgene SA - Product Pipeline Review - H2 2011

Transgene SA – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Transgene SA - Product Pipeline Review - H2 2011” provides data on the Transgene SA’s research...

November 2011
FROM

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2013

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2013', provides an overview...

August 2013
FROM

Multiple Sclerosis - Pipeline Review, H2 2013

Multiple Sclerosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Sezary Syndrome - Pipeline Review, H1 2013

Sezary Syndrome – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sezary Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

May 2013
FROM
Loading Indicator